Photoactivated cell-killing involving a low molecular weight, donor-acceptor diphenylacetylene
- PMID: 31123578
- PMCID: PMC6495688
- DOI: 10.1039/c9sc00199a
Photoactivated cell-killing involving a low molecular weight, donor-acceptor diphenylacetylene
Abstract
Photoactivation of photosensitisers can be utilised to elicit the production of ROS, for potential therapeutic applications, including the destruction of diseased tissues and tumours. A novel class of photosensitiser, exemplified by DC324, has been designed possessing a modular, low molecular weight and 'drug-like' structure which is bioavailable and can be photoactivated by UV-A/405 nm or corresponding two-photon absorption of near-IR (800 nm) light, resulting in powerful cytotoxic activity, ostensibly through the production of ROS in a cellular environment. A variety of in vitro cellular assays confirmed ROS formation and in vivo cytotoxic activity was exemplified via irradiation and subsequent targeted destruction of specific areas of a zebrafish embryo.
Figures









References
-
- Holmström K. M., Finkel T. Nat. Rev. Mol. Cell Biol. 2014;15:411–421. - PubMed
-
- Dolmans D. E. J. G. J., Fukumura D., Jain R. K. Nat. Rev. Cancer. 2003;3:380–387. - PubMed
-
- Schweitzer C., Mehrdad Z., Noll A., Grabner E.-W., Schmidt R. J. Phys. Chem. A. 2003;107:2192–2198.
-
- Schmidt R. Photochem. Photobiol. 2007;82:1161–1177. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources